Ryman Healthcare Limited
RHCGF
$1.41
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 104.80M | 103.71M | 102.24M | 100.84M | 95.79M |
| Total Other Revenue | 6.83M | 6.76M | 9.80M | 9.67M | 4.75M |
| Total Revenue | 111.63M | 110.47M | 112.05M | 110.51M | 100.54M |
| Cost of Revenue | 104.49M | 103.40M | 109.95M | 108.44M | 87.85M |
| Gross Profit | 7.14M | 7.06M | 2.10M | 2.07M | 12.68M |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 7.77M | 7.68M | 5.39M | 5.32M | 6.57M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 112.25M | 111.09M | 115.34M | 113.76M | 94.42M |
| Operating Income | -629.10K | -622.60K | -3.30M | -3.25M | 6.12M |
| Income Before Tax | 53.44M | 52.88M | -88.31M | -87.10M | 37.40M |
| Income Tax Expenses | 24.59M | 24.33M | -32.60M | -32.15M | -19.19M |
| Earnings from Continuing Operations | 28.85M | 28.55M | -55.71M | -54.94M | 56.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.85M | 28.55M | -55.71M | -54.94M | 56.59M |
| EBIT | -629.10K | -622.60K | -3.30M | -3.25M | 6.12M |
| EBITDA | 6.78M | 6.70M | 369.80K | 1.61M | 12.41M |
| EPS Basic | 0.04 | 0.04 | -0.08 | -0.08 | 0.08 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | 0.00 |
| EPS Diluted | 0.04 | 0.04 | -0.08 | -0.08 | 0.08 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | 0.00 |
| Average Basic Shares Outstanding | 687.64M | 687.64M | 687.64M | 687.64M | 687.64M |
| Average Diluted Shares Outstanding | 687.64M | 687.64M | 687.64M | 687.64M | 687.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
